<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0711211264
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AMLOPINE 10MG CAPSULES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMLODIPINE BESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        64.40
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Amlopine contains the active substance amlodipine which belongs to a group of medicines called calcium channel blockers. Amlopine is used to treat high blood pressure (hypertension) or a certain type of chest pain called angina, a form of which is Prinzmetal&rsquo;s or variant angina. In patients with high blood pressure your medicine works by relaxing blood vessels, so that blood passes through them more easily. In patients with angina Amlopine works by improving blood supply to the heart muscle which then receives more oxygen and as a result chest pain is prevented. Your medicine does not provide immediate relief of chest pain from angina.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Amlopine </strong></p><p>If you are allergic (hypersensitive) to amlodipine, or any of the other ingredients of your medicine listed in section 6, or to any other calcium channel blockers. This may be itching, reddening of the skin or difficulty in breathing. If you have severe low blood pressure (hypotension). If you have narrowing of the aortic heart valve (aortic stenosis), or cardiogenic shock (a condition where your heart is unable to supply enough blood to the body). If you suffer from heart failure after a heart attack.</p><p><strong>Take special care with Amlopine</strong></p><p>You should inform your doctor if you have or have had any of the following conditions: Recent heart attack. Heart failure. Severe increase in blood pressure (Hypertensive crisis). Liver disease. You are elderly and your dose needs to be increased.</p><p><strong>Use in children and adolescents</strong></p><p>Amlopine has not been studied in children under the age of 6 years. Amlopine should only be used for hypertension in children and adolescents from 6 years to 17 years of age (see section 3). For more information, talk to your doctor.</p><p><strong>Taking other medicines</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Amlopine may affect or be affected by other medicines, such as: Ketoconazole, itraconazole (anti-fungal medicines). Ritonavir, indinavir, nelfinavir (so called protease inhibitors used to treat HIV). Rifampicin, erythromycin, clarithromycin (antibiotics). Hypericumperforatum (St. John&rsquo;s Wort). Verapamil, diltiazem (heart medicines) Dantrolene (infusion for severe body temperature abnormalities). Simvastatin (a cholesterol lowering medicine). Amlopine may lower your blood pressure even more if you are already taking other medicines to treat your high blood pressure.</p><p><strong>Taking Amlopine with food and drink </strong></p><p>Grapefruit juice and grapefruit should not be consumed by people who are taking Amlopine. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Amlopine.</p><p>&nbsp;</p><p><strong>Pregnancy </strong></p><p>The safety of amlodipine in human pregnancy has not been established. If you think you might be pregnant, or are planning to get pregnant, you must tell your doctor before you take Amlopine.</p><p><strong>Breast-feeding</strong></p><p>It is not known whether amlodipine is passed into breast milk. If you are breast-feeding or about to start breast-feeding you must tell your doctor before taking Amlopine.</p><p><strong>Driving and using machines</strong></p><p>Amlopine may affect your ability to drive or use machines. If the capsules make you feel sick, dizzy or tired, or give you a headache, do not drive or use machines and contact your doctor immediately.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take your medicine exactly as you doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual initial dose is Amlopine 5 mg once daily. The dose can be increased to Amlopine 10 mg once daily. Your medicine can be used before or after food and drinks. You should take your medicine at the same time each day with a drink of water. Do not take Amlopine with grapefruit juice. Use in children and adolescents For children and adolescents (6-17 years old), the recommended usual starting dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day. Amlodipine 2.5 mg is not currentlyavailable and the 2.5 mg dose cannot be obtained with Amlopine 5 mg capsules as these capsules are not manufactured to break into two equal halves. It is important to keep taking the capsules. If you take more Amlopine than you should Taking too may capsules may cause your blood pressure to become low or even dangerously low. You may feel dizzy, lightheaded, faint or weak. If blood pressure drop is severe enough shock can occur. Your skin could feel cool and clammy and you could lose consciousness. Seek immediate medical attention if you take too many Amlopine capsules. If you forget to take Amlopine Do not worry. If you forget to take a capsule, leave out that dose completely. Take your next dose at the right time. Do not take a double dose to make up for a missed dose. If you stop using Amlopine Your doctor will advise you how long to take your medicine. Your condition may return if you stop using your medicine before you are advised. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Amlopine can cause side effects, although not everybody gets them. Visit your doctor immediately if you experience any of the following very rare, severe side effects after taking this medicine. Sudden wheeziness, chest pain, shortness of breath or difficulty in breathing. Swelling of eyelids, face or lips. Swelling of the tongue and throat which causes great difficulty breathing. Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome) or other allergic reactions.</p><p>Heart attack, abnormal heart beat. Inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell. The following common side-effects have been reported. If any of these cause you problems or if they last for more than one week, you should contact your doctor. Common: affects 1 to 10 users in 100 Headache, dizziness, sleepiness (especially at the beginning of treatment). Palpitations (awareness of your heart beat), flushing. Abdominal pain, feeling sick (nausea). Ankle swelling (oedema), tiredness. Other side-effects that have been reported include the following list. If any of these get serious, or if you notice any side-effects not listed in this leaflet, please tell your doctor or pharmacist. Uncommon: affects 1 to 10 users in 1,000 Mood changes, anxiety, depression, sleeplessness. Trembling, taste abnormalities, fainting, weakness. Numbness or tingling sensation in your limbs; loss of pain sensation. Visual disturbances, double vision, ringing in the ears. Low blood pressure. Sneezing/running nose caused by inflammation of the lining of the nose (rhinitis). Altered bowel habits, diarrhoea, constipation, indigestion, dry mouth, vomiting (being sick). Hair loss, increased sweating, itchy skin, red patches on skin, skin discolouration. Disorder in passing urine, increased need to urinate at night, increased number of times of passing urine. Inability to obtain an erection, discomfort or enlargement of the breasts in men. Weakness, pain, feeling unwell. Joint or muscle pain, muscle cramps, back pain. Weight increase or decrease. Rare: affects 1 to 10 users in 10,000 Confusion. Very rare: affects less than 1 user in 10,000 Decreased numbers of white blood cells, decrease in blood platelets which may result in unusual bruising or easy bleeding (red blood cell damage). Excess sugar in blood (hyperglycaemia). A disorder of the nerves which can cause weakness, tingling or numbness. Cough, swelling of the gums. Abdominal bloating (gastritis). Abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), liver enzyme increase which may have an effect on some medical tests. Increased muscle tension. Inflammation of blood vessels, often with skin rash.&nbsp;Sensitivity to light. Disorders combining rigidity, tremor, and/or movement disorders. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children. Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in Amlopine 5 mg capsules is amlodipine (as besilate). The active substance in Amlopine 10 mg capsules is amlodipine (as besilate). The other ingredients are Avicel PH 102, maize starch, magnesium stearate, gelatin Caps.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Amlopine 5mg Capsules: hard gelatin capsule with opaque dark green body and opaque
standard yellow cap containing a white to off-white fine powder. The capsule is printed
with ‘AMLOPINE 5mg” on both parts. Amlopine 5 mg Capsules are available in blister
packs containing 30 capsules.
Amlopine 10mg Capsules: hard gelatin capsule with opaque light grey body and cap
containing a white to off-white fine powder. The capsule is printed with ‘AMLOPINE
10mg” on both parts. Amlopine 10 mg Capsules are available in blister packs containing
30 capsules. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO</p><p>AlQassim pharmaceutical plant Saudi Pharmaceutical Industries &amp; Medical Appliance Corporation</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                February 2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوى&nbsp;أملوبين&nbsp;على&nbsp;أملوديبين&nbsp;كمادة فعالة&nbsp;والتى&nbsp;تنتمى&nbsp;إلى مجموعة مثبطات ممرات الكالسيوم.&nbsp;</p><p>يستخدم&nbsp;أملوبين&nbsp;فى&nbsp;علاج ضغط الدم المرتفع أو نوع من أنواع الذبحة الصدرية&nbsp;وهى&nbsp;برينزميتال&nbsp;أو الذبحة الصدرية المتنوعة (أحد أنواع ألم الصدر).&nbsp;</p><p>لمرضى ارتفاع ضغط الدم يقوم&nbsp;أملوبين&nbsp;بعمل ارتخاء&nbsp;فى&nbsp;الأوعية الدموية مما يسمح بمرور الدم فيها بشكل أسهل أما لمرضى الذبحة الصدرية فيقوم&nbsp;أملوبين&nbsp;بتحسين تغذية عضلة القلب مما يسمح لها باستقبال كمية أكبر من الأوكسجين مما يمنع ألم الذبحة ولكنه لا يعتبر علاج فورى لألم الذبحة الصدرية.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>امتنع عن تناول كبسولات&nbsp;أملوبين&nbsp;واخبر&nbsp;طبيبك&nbsp;فى&nbsp;الحالات الآتية:&nbsp;&nbsp;</p><ul><li><p>إذا كنت تعاني من فرط التحسس لمادة&nbsp;أملوديبين&nbsp;أو&nbsp;أى&nbsp;من مثبطات ممرات الكالسيوم الأخرى أو&nbsp;أى&nbsp;من المكونات الأخرى المذكورة&nbsp;فى&nbsp;فقرة&nbsp;6.وأعراض&nbsp;فرط التحسس&nbsp;هى&nbsp;الحكة واحمرار الجلد&nbsp;و صعوبة&nbsp;فى&nbsp;التنفس.&nbsp;</p></li><li><p>إذا كان لديك هبوط حاد&nbsp;فى&nbsp;ضغط الدم.&nbsp;</p></li></ul><ul><li><p>إذا كنت تعاني من ضيق&nbsp;فى&nbsp;الصمام&nbsp;الأورطى&nbsp;بالقلب (ضيق&nbsp;أورطى) أو صدمة قلبية (حالة لا يستطيع فيها القلب ضخ كمية كافية من الدم للجسم).&nbsp;</p></li><li><p>إذا كنت مصابا بفشل&nbsp;قلبى&nbsp;بعد نوبة قلبية.&nbsp;</p></li></ul><p>&nbsp;</p><p>ينبغى&nbsp;توخى الحذر عند تناول كبسولات&nbsp;أملوبين&nbsp;فى&nbsp;الحالات الآتية:&nbsp;</p><p>ينبغى&nbsp;اخبار طبيبك إذا كنت&nbsp;تعانى&nbsp;أو عانيت من&nbsp;أى&nbsp;من الحالات التالية:&nbsp;</p><ul><li><p>نوبة قلبية حديثا.&nbsp;</p></li><li><p>فشل&nbsp;قلبى.&nbsp;</p></li><li><p>ارتفاع حاد&nbsp;فى&nbsp;ضغط الدم (أزمة ارتفاع ضغط الدم).&nbsp;</p></li><li><p>مرض&nbsp;كبدى.&nbsp;</p></li><li><p>إذا كنت من كبار السن فقد تحتاج إلى زيادة الجرعة.&nbsp;</p></li></ul><p>&nbsp;</p><p>الإستخدام&nbsp;للأطفال&nbsp;و المراهقين&nbsp;</p><p>أملوبين&nbsp;لم يتم دراسته تحت سن 6&nbsp;سنوات.أملوبين&nbsp;ينبغى&nbsp;فقط استخدامه لضغط الدم المرتفع للأطفال والمراهقين من 6 سنوات&nbsp;و حتى&nbsp;17 سنة (انظر فقرة 3)&nbsp;</p><p>لمزيد من المعلومات استشر طبيبك.&nbsp;</p><p>&nbsp;</p><p>تناول أدوية أخرى&nbsp;</p><p>يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت في الآونة الأخيرة أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.&nbsp;</p><p>قد يؤثر&nbsp;أملوبين&nbsp;فى&nbsp;أو يتأثر بأدوية أخرى مثل:&nbsp;</p><ul><li><p>كيتوكونازول&nbsp;و&nbsp;إتراكونازول&nbsp;(مضادات للفطريات)&nbsp;</p></li><li><p>ريتونافير&nbsp;و&nbsp;إندينافير&nbsp;و&nbsp;نيلفينافير&nbsp;(يستخدم لعلاج مرض ضعف المناعة المكتسبة&nbsp;الأيدز)&nbsp;</p></li></ul><ul><li><p>ريفامبيسين&nbsp;و&nbsp;اريثروميسين&nbsp;و&nbsp;كلاريثروميسين&nbsp;(مضادات حيوية)&nbsp;</p></li><li><p>هايبركم&nbsp;بيرفوراتم&nbsp;(سانت جون ورت)&nbsp;</p></li><li><p>فيراباميل&nbsp;و&nbsp;ديلتيازيم&nbsp;(أدوية للقلب)&nbsp;</p></li><li><p>دانترولين&nbsp;(حقن للتغيرات&nbsp;الحاده&nbsp;فى&nbsp;درجة حرارة الجسم)&nbsp;</p></li><li><p>سيمفاستاتين&nbsp;(دواء لتقليل نسبة&nbsp;الكوليستيرول)&nbsp;</p></li></ul><p>أملوبين&nbsp;قد يقلل ضغط الدم أكثر&nbsp;اذا&nbsp;كنت تتناول أدوية أخرى لعلاج ضغط الدم المرتفع.&nbsp;&nbsp;</p><p>&nbsp;</p><p>تناول&nbsp;أملوبين&nbsp;مع الطعام والشراب&nbsp;</p><p>ينبغى&nbsp;عدم تناول&nbsp;أملوبين&nbsp;مع الجريب فروت أو عصيره لأنه قد يؤدى إلى زيادة&nbsp;فى&nbsp;فى&nbsp;مستوى مادة&nbsp;الأملوديبين&nbsp;فى&nbsp;الدم مما يؤدى إلى زيادة&nbsp;فى&nbsp;مفعول&nbsp;أملوبين&nbsp;فى&nbsp;خفض ضغط الدم.&nbsp;</p><p>&nbsp;</p><p>الحمل&nbsp;</p><p>أمان&nbsp;أملوبين&nbsp;فى&nbsp;الحمل لم يتم تأكيده لذلك فضلا&nbsp;أخبرى&nbsp;الطبيب إذا كنت حامل أو تعتقدين بأنك حامل أو تخططين لأن&nbsp;تصبحى&nbsp;حامل قبل تناولك&nbsp;أملوبين.&nbsp;</p><p>&nbsp;</p><p>الرضاعة&nbsp;</p><p>عبور&nbsp;أملوبين&nbsp;للبن الأم غير معلوم لذلك&nbsp;اذا&nbsp;كنتى&nbsp;ترضعى&nbsp;طفلك أو&nbsp;ستبدأين&nbsp;فى&nbsp;الإرضاع فضلا&nbsp;أخبرى&nbsp;طبيبك قبل تناول&nbsp;أملوبين.&nbsp;</p><p>&nbsp;</p><p>القيادة واستخدام الآلات&nbsp;</p><p>أملوبين&nbsp;قد يؤثر&nbsp;فى&nbsp;قدرتك على القيادة&nbsp;و استخدام&nbsp;الآلات.اذا&nbsp;جعلتك كبسولات&nbsp;أملوبين&nbsp;تصاب بدوار أو تعب أو صداع لا تقود أو تستخدم آلات واتصل بطبيبك فورا.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قم دائما بتناول كبسولات&nbsp;أملوبين&nbsp;تماما كما أخبرك الطبيب المعالج. إذا كنت غير واثق يجب عليك التحقق من خلال الطبيب أو&nbsp;الصيدلى.&nbsp;</p><p>الجرعة المبدئية المعتادة من&nbsp;أملوبين&nbsp;هى&nbsp;5 مجم مرة يوميا&nbsp;والتى&nbsp;قد تزيد إلى 10 مجم مرة يوميا.&nbsp;</p><p>هذا الدواء قد يستخدم قبل أو بعد الأكل أو&nbsp;الشرب.ينبغى&nbsp;تناول الدواء&nbsp;فى&nbsp;نفس الوقت كل يوم مع الماء ولكن لا تتناول&nbsp;أملوبين&nbsp;مع عصير الجريب فروت.&nbsp;</p><p>&nbsp;</p><p>الإستخدام&nbsp;للأطفال&nbsp;و المراهقين&nbsp;&nbsp;</p><p>الجرعة&nbsp;الموصى&nbsp;بها للأطفال&nbsp;و المراهقين&nbsp;(6-17 سنة)&nbsp;هى&nbsp;2.5 مجم&nbsp;فى&nbsp;اليوم&nbsp;و الجرعة&nbsp;القصوى&nbsp;هى&nbsp;5 مجم&nbsp;فى&nbsp;اليوم.&nbsp;</p><p>أملوبين&nbsp;2.5 مجم غير متوفر&nbsp;و لا&nbsp;يمكن الحصول على هذه الجرعة من كبسولات&nbsp;أملوبين&nbsp;5 مجم لأن هذه الكبسولات غير مصممة لتنقسم إلى نصفين متساويين.&nbsp;</p><p>من المهم&nbsp;الإنتظام&nbsp;على هذه الكبسولات.&nbsp;</p><p>&nbsp;</p><p>إذا قمت بتناول كبسولات&nbsp;أملوبين&nbsp;أكثر مما&nbsp;ينبغى&nbsp;</p><p>إذا قمت بتناول كبسولات&nbsp;أملوبين&nbsp;أكثر مما&nbsp;ينبغى، فقد تتعرض لهبوط&nbsp;فى&nbsp;ضغط الدم&nbsp;والذى&nbsp;قد يكون خطير فربما تشعر بدوار&nbsp;و ضعف&nbsp;وقد تصاب بإغماء. ولو كان هذا الهبوط حاد قد يحدث صدمة وقد تشعر ببرودة&nbsp;فى&nbsp;الجلد وقد تفقد&nbsp;الوعى&nbsp;وفى&nbsp;أى&nbsp;من الأحوال السابقة تواصل مع طبيبك المعالج فورا.&nbsp;</p><p>&nbsp;</p><p>فى&nbsp;حالة نسيان تناول كبسولات&nbsp;أملوبين&nbsp;</p><p>لا تقلق&nbsp;اذا&nbsp;نسيت تناول كبسولات&nbsp;أملوبين&nbsp;قم بتناول الجرعة القادمة&nbsp;فى&nbsp;الوقت المعتاد&nbsp;و لا&nbsp;تقم بتناول جرعة مضاعفة لتعويض الجرعة الفائتة.&nbsp;</p><p>&nbsp;</p><p>فى&nbsp;حالة التوقف عن تناول كبسولات&nbsp;أملوبين&nbsp;</p><p>سوف يخبرك طبيبك عن مدة العلاج فقد تعود الأعراض&nbsp;اذا&nbsp;توقفت عن تناول الدواء دون استشارة الطبيب.&nbsp;&nbsp;</p><p>إذا كانت لديك أسئلة إضافية حول استخدام هذا الدواء، فضلا اسأل الطبيب أو&nbsp;الصيدلى.&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية،&nbsp;أملوبين&nbsp;قد يسبب آثار جانبية، وإن لم تكن تحدث لكل من يتناول هذا الدواء.&nbsp;</p><p>استشر طبيبك فورا&nbsp;اذا&nbsp;حدث لك بعد تناول&nbsp;أملوبين&nbsp;أى&nbsp;من الأعراض الجانبية النادرة&nbsp;و الحادة&nbsp;التالية.&nbsp;</p><ul><li><p>أزيز أو ألم&nbsp;فى&nbsp;الصدر أو قصر&nbsp;و صعوبة&nbsp;فى&nbsp;التنفس.&nbsp;</p></li><li><p>تورم&nbsp;فى&nbsp;جفون العين&nbsp;و الوجه&nbsp;والشفاه.&nbsp;</p></li><li><p>تورم&nbsp;فى&nbsp;اللسان&nbsp;و الحلق&nbsp;مما يسبب صعوبة&nbsp;فى&nbsp;التنفس.&nbsp;</p></li></ul><ul><li><p>تفاعلات حادة&nbsp;فى&nbsp;الجلد&nbsp;وهى&nbsp;تشمل حكة شديدة&nbsp;فى&nbsp;الجلد واحمرار الجلد بشكل كامل&nbsp;فى&nbsp;الجسم مع ظهور تقرحات&nbsp;و تقشير&nbsp;و تورم&nbsp;فى&nbsp;الجلد والتهاب&nbsp;فى&nbsp;الأغشية المخاطية (متلازمة&nbsp;ستيفينز&nbsp;جونسون) أو&nbsp;أى&nbsp;تفاعلات أخرى للحساسية.&nbsp;</p></li><li><p>نوبة قلبية&nbsp;و عدم&nbsp;انتظام&nbsp;فى&nbsp;ضربات القلب.&nbsp;</p></li><li><p>التهاب&nbsp;فى&nbsp;البنكرياس&nbsp;والذى&nbsp;قد يسبب ألم حاد&nbsp;فى&nbsp;البطن والظهر مع الشعور بالتعب.&nbsp;</p></li></ul><p>الأعراض الجانبية الشائعة التالية تم رصدها&nbsp;اذا&nbsp;حدث لك&nbsp;أى&nbsp;منها أو&nbsp;اذا&nbsp;استمرت لأكثر من أسبوع استشر طبيبك:&nbsp;</p><p>&nbsp;</p><p>شائعة:&nbsp;تؤثر&nbsp;فى&nbsp;من 1 إلى 10 مستخدمين&nbsp;فى&nbsp;كل 100 مستخدم&nbsp;</p><ul><li><p>صداع&nbsp;و دوار&nbsp;و نعاس&nbsp;(خصوصا&nbsp;فى&nbsp;بداية العلاج).&nbsp;</p></li><li><p>خفقان (الإحساس بضربات القلب)&nbsp;و توهج.&nbsp;</p></li><li><p>ألم&nbsp;فى&nbsp;البطن&nbsp;و شعور&nbsp;بالإعياء (الغثيان).&nbsp;</p></li><li><p>تورم&nbsp;فى&nbsp;الكاحل (استسقاء)&nbsp;و ارهاق.&nbsp;</p></li></ul><p>الأعراض الجانبية التالية تم رصدها&nbsp;اذا&nbsp;حدث لك&nbsp;أى&nbsp;منها وأصبحت خطيرة أو حدث لك&nbsp;أى&nbsp;عرض&nbsp;جانبى&nbsp;آخر غير مذكور&nbsp;فى&nbsp;النشرة فضلا استشر طبيبك.&nbsp;</p><p>&nbsp;</p><p>غير شائعة:&nbsp;تؤثر&nbsp;فى&nbsp;من 1 إلى 10 مستخدمين&nbsp;فى&nbsp;كل 1000 مستخدم&nbsp;</p><ul><li><p>تغييرات&nbsp;فى&nbsp;الحالة المزاجية مثل القلق و&nbsp;الإكتئاب&nbsp;و الأرق.&nbsp;</p></li><li><p>ارتجاف&nbsp;و تغييرات&nbsp;فى&nbsp;حاسة التذوق&nbsp;و إغماء&nbsp;و ضعف&nbsp;عام.&nbsp;</p></li></ul><ul><li><p>شعور بالوخز&nbsp;فى&nbsp;الأطراف وفقد الشعور&nbsp;لاألم.&nbsp;</p></li><li><p>اضطرابات&nbsp;فى&nbsp;الرؤية أو ازدواج&nbsp;الرؤية&nbsp; أو&nbsp;رنين&nbsp;فى&nbsp;الأذن.&nbsp;</p></li><li><p>انخفاض&nbsp;فى&nbsp;ضغط الدم.&nbsp;</p></li><li><p>عطس&nbsp;و رشح&nbsp;بالأنف بسبب التهاب الأغشية المبطنة للأنف.&nbsp;</p></li><li><p>مشاكل متعلقة بالأمعاء&nbsp;مثل:اسهال&nbsp;أو إمساك أو سوء هضم أو جفاف الفم أو&nbsp;قئ.&nbsp;</p></li></ul><ul><li><p>فقدان الشعر أو زيادة&nbsp;العرق&nbsp; أو&nbsp;حكة&nbsp;فى&nbsp;الجلد أو وجود بقع حمراء على الجلد أو تغير لون الجلد.&nbsp;</p></li><li><p>مشاكل&nbsp;فى&nbsp;التبول&nbsp;مثل:زيادة&nbsp;الرغبة&nbsp;فى&nbsp;التبول أثناء الليل&nbsp;و زيادة&nbsp;عدد مرات التبول.&nbsp;</p></li><li><p>عدم قدرة&nbsp;و مشقة&nbsp;فى&nbsp;الحصول على&nbsp;الإنتصاب&nbsp;و تضخم&nbsp;فى&nbsp;الصدر عند الرجال.&nbsp;</p></li><li><p>تعب&nbsp;و ألم&nbsp;و شعور&nbsp;بالإعياء.&nbsp;</p></li><li><p>ألم&nbsp;فى&nbsp;المفاصل والعضلات&nbsp;و تشنجات&nbsp;فى&nbsp;العضلات&nbsp;و ألم&nbsp;فى&nbsp;الظهر.&nbsp;</p></li></ul><ul><li><p>زيادة أو نقص&nbsp;فى&nbsp;الوزن.&nbsp;</p></li></ul><p>&nbsp;</p><p>نادرة:&nbsp;تؤثر&nbsp;فى&nbsp;من 1 إلى 10 مستخدمين&nbsp;فى&nbsp;كل 10000 مستخدم&nbsp;</p><ul><li><p>ارتباك&nbsp;</p></li></ul><p>نادرة جدا: تؤثر&nbsp;فى&nbsp;أقل من 1 مستخدم&nbsp;فى&nbsp;كل 10000 مستخدم&nbsp;</p><ul><li><p>نقص عدد خلايا الدم البيضاء&nbsp;و الصفائح&nbsp;فى&nbsp;الدم مما يتسبب&nbsp;فى&nbsp;الكدمات وسهولة النزف.&nbsp;</p></li><li><p>زيادة السكر&nbsp;فى&nbsp;الدم.&nbsp;</p></li><li><p>اضطراب&nbsp;فى&nbsp;الأعصاب مما يؤدى إلى ضعف&nbsp;و وخز.&nbsp;</p></li><li><p>كحة&nbsp;و تورم&nbsp;فى&nbsp;اللثة.&nbsp;</p></li><li><p>انتفاخ البطن.&nbsp;</p></li></ul><ul><li><p>اضطراب&nbsp;فى&nbsp;وظائف الكبد&nbsp;و التهاب&nbsp;فى&nbsp;الكبد&nbsp;و اصفرار&nbsp;الجلد (الصفراء) وزيادة&nbsp;فى&nbsp;انزيمات الكبد مما قد يؤثر على بعض التحاليل الطبية.&nbsp;</p></li><li><p>زيادة توتر العضلات.&nbsp;</p></li><li><p>التهاب الأوعية الدموية غالبا مع وجود طفح&nbsp;جلدى.&nbsp;</p></li><li><p>حساسية للضوء.&nbsp;</p></li><li><p>اضطرابات تمزج تصلب مع ارتجاف مع/أو اضطرابات&nbsp;فى&nbsp;الحركة.&nbsp;</p></li></ul><p>إذا لاحظت أن أيا من هذه الآثار الجانبية أصبح&nbsp;جسيما،&nbsp; أو&nbsp;إذا لاحظت ظهور&nbsp;أى&nbsp;أعراض جانبية لم ترد&nbsp;فى&nbsp;هذه النشرة فإنه يرجى أن تخبر طبيبك المعالج أو&nbsp;الصيدلى&nbsp;الذى&nbsp;تتعامل معه بشأنها.&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ الدواء بعيدا عن متناول ونظر الاطفال.&nbsp;</p><p>يحفظ&nbsp;فى&nbsp;درجة حرارة أقل من&nbsp;30&deg;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>محتويات كبسولات&nbsp;أملوبين&nbsp;</p><ul><li><p>المادة الفعالة&nbsp;فى&nbsp;كبسولات&nbsp;أملوبين&nbsp;5 مجم&nbsp;هى&nbsp;أملوديبين&nbsp;بيسايليت.&nbsp;</p></li><li><p>المادة الفعالة&nbsp;فى&nbsp;كبسولات&nbsp;أملوبين&nbsp;10 مجم&nbsp;هى&nbsp;أملوديبين&nbsp;بيسايليت.&nbsp;</p></li></ul><p>&nbsp;</p><p>مكونات أخرى:&nbsp;افيسيل&nbsp;&nbsp;PH&nbsp;102&nbsp; و&nbsp;نشا&nbsp;ذرة&nbsp;و&nbsp;ستياريت&nbsp;الماغنسيوم&nbsp;و&nbsp;جيلاتين.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">أملوبين&nbsp;5 مجم&nbsp;يتوافر على هيئة كبسولات جيلاتينية صلبة ذات لون أخضر قاتم معتم&nbsp;و جزء&nbsp;مغطى ذا لون أصفر معتم&nbsp;وتحتوى&nbsp;على بودرة ذات لون أبيض إلى&nbsp;سمنى.ومطبوع&nbsp;على الكبسولة &quot;AMLOPINE 5mg&quot; على الجزئين.&nbsp;</p><p style="text-align:right">تتوفر كبسولات&nbsp;أملوبين&nbsp;5 مجم&nbsp;فى&nbsp;عبوات&nbsp;تحتوى&nbsp;كل عبوة على 30 كبسولة&nbsp;&nbsp;</p><p style="text-align:right">أملوبين&nbsp;10 مجم&nbsp;يتوافر على هيئة كبسولات جيلاتينية صلبة ذات لون&nbsp;رصاصى&nbsp;فاتح معتم&nbsp;وتحتوى&nbsp;على بودرة ذات لون أبيض إلى&nbsp;سمنى.ومطبوع&nbsp;على الكبسولة &quot;AMLOPINE 10mg&quot; على الجزئين.&nbsp;</p><p style="text-align:right">تتوفر كبسولات&nbsp;أملوبين&nbsp;10 مجم&nbsp;فى&nbsp;عبوات&nbsp;تحتوى&nbsp;كل عبوة على 30 كبسولة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>إنتاج&nbsp;الدوائية&nbsp;</p><p>مصنع الأدوية بالقصيم&nbsp;</p><p>الشركة السعودية للصناعات الدوائية والمستلزمات الطبية.&nbsp;</p><p>المملكة العربية السعودية&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             فبراير 2016.   
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AMLOPINE 5 mg capsule
AMLOPINE 10 mg capsule
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains amlodipine besilate equivalent to 5mg amlodipine
Each capsule contains amlodipine besilate equivalent to 10mg amlodipine
Excipients:
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsules.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypertension Chronic stable angina pectoris Vasospastic (Prinzmetal&#39;s) angina</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>Adults</p><p>For both hypertension and angina, the usual initial dose is 5 mg Amlopine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient&#39;s response. In hypertensive patients, Amlopine has been used in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotensin converting enzyme inhibitor. For angina, Amlopine may be used as monotherapy or in combination with other antianginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers. No dose adjustment of Amlopine is required upon concomitant administration of thiazide diuretics, beta blockers, and angiotensin-converting enzyme inhibitors.</p><p>Special populations</p><p>Elderly</p><p>Amlopine used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care (see sections 4.4 and 5.2). Hepatic impairment Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautious and should start at the lower end of the dosing range (see sections 4.4 and 5.2). The pharmacokinetics of amlodipine have not been studied in severe hepatic impairment. Amlodipine should be initiated at the lowest dose and titrated slowly in patients with severe hepatic impairment. Renal impairment Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amlodipine is not dialyzable. Pediatric population Children and adolescents with hypertension from 6 years to 17 years of age The recommended antihypertensive oral dose in pediatric patients&rsquo; ages 6-17 years is 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients (see sections 5.1 and 5.2). Doses of amlodipine 2.5 mg are not possible with this medicinal product. Children under 6 years old No data are available. Method of administration Capsule for oral administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amlodipine is contraindicated in patients with:
Hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients.
Severe hypotension.
Shock (including cardiogenic shock).
Obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).
Hemodynamically unstable heart failure after acute myocardial infarction.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety and efficacy of amlodipine in hypertensive crisis has not been established. Patients with cardiac failure</p><p>Patients with heart failure should be treated with caution. In a long-term, placebo controlled study in patients with severe heart failure (NYHA class III and IV) the reported incidence of pulmonary edema was higher in the amlodipine treated group than in the placebo group (see section 5.1). Calcium channel blockers, including amlodipine, should be used with caution in patients with congestive heart failure, as they may increase the risk of future cardiovascular events and mortality. Use in patients with impaired hepatic function The half-life of amlodipine is prolonged and AUC values are higher in patients with impaired liver function; dosage recommendations have not been established. Amlodipine should therefore be initiated at the lower end of the dosing range and caution should be used, both on initial treatment and when increasing the dose. Slow dose titration and careful monitoring may be required in patients with severe hepatic impairment. Use in elderly patients In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2). Use in renal failure Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialyzable.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Contraindicated combination</strong></p><p>Effects of other medicinal products on amlodipine CYP3A4 inhibitors: Concomitant use of amlodipine with strong or moderate CYP3A4 inhibitors (protease inhibitors, azole antifungals, macrolides like erythromycin or clarithromycin, verapamil or diltiazem) may give rise to significant increase in amlodipine exposure. The clinical translation of these PK variations may be more pronounced in the elderly. Clinical monitoring and dose adjustment may thus be required. CYP3A4 inducers: There is no data available regarding the effect of CYP3A4 inducers on amlodipine. The concomitant use of CYP3A4 inducers (e.g., rifampicin, hypericum perforatum) may give a lower plasma concentration of amlodipine. Amlodipine should be used with caution together with CYP3A4 inducers. Administration of amlodipine with grapefruit or grapefruit juice is not recommended as bioavailability may be increased in some patients resulting in increased blood pressure lowering effects. Dantrolene (infusion): In animals, lethal ventricular fibrillation and cardiovascular collapse are observed in association with hyperkalemia after administration of verapamil and intravenous dantrolene. Due to risk of hyperkalemia, it is recommended that the coadministration of calcium channel blockers such as amlodipine be avoided in patients susceptible to malignant hyperthermia and in the management of malignant hyperthermia.</p><p>Effects of amlodipine on other medicinal products The blood pressure lowering effects of amlodipine adds to the blood pressure-lowering effects of other medicinal products with antihypertensive properties. In clinical interaction studies, amlodipine did not affect the pharmacokinetics of atorvastatin, digoxin, warfarin or cyclosporin. Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone. Limit the dose of simvastatin to 20 mg daily in patients on amlodipine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>Pregnancy category C. The safety of amlodipine in human pregnancy has not been established. In animal studies, reproductive toxicity was observed at high doses (see section 5.3). Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and fetus.</p><p>Breast-feeding</p><p>It is not known whether amlodipine is excreted in breast milk. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of amlodipine therapy to the mother.</p><p>Fertility</p><p>Reversible biochemical changes in the head of spermatozoa have been reported in some patients treated by calcium channel blockers. Clinical data are insufficient regarding the potential effect of amlodipine on fertility. In one rat study, adverse effects were found on male fertility (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amlodipine can have minor or moderate influence on the ability to drive and use machines. If patients taking amlodipine suffer from dizziness, headache, fatigue or nausea the ability to react may be impaired. Caution is recommended especially at the start of treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile The most commonly reported adverse reactions during treatment are somnolence, dizziness, headache, palpitations, flushing, abdominal pain, nausea, ankle swelling, edema&nbsp;and fatigue. Tabulated list of adverse reactions The following adverse reactions have been observed and reported during treatment with amlodipine with the following frequencies: Very common (&ge;1/10); common ( &ge;1/100 to &lt;1/10); uncommon (&ge; 1/1,000 to &le;1/100); rare (&ge; 1/10,000 to &le;1/1,000); very rare (&le;1/10,000). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Leukocytopenia, thrombocytopenia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Very rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Allergic reactions</p><p>Hyperglycemia</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp; Psychiatric disorders</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Depression, mood changes (including anxiety), insomnia</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>Common</p></td><td style="vertical-align:top"><p>Confusion</p><p>&nbsp;</p><p>Somnolence, dizziness, headache (especially at the beginning of the treatment)</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Eye disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Visual disturbance (including diplopia)</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Tinnitus</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Cardiac disorders</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Common</p><p>Uncommon</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p><p>Common</p></td><td style="vertical-align:top"><p>Palpitations</p><p>Arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation)</p><p>&nbsp;</p><p>Myocardial infarction</p><p>Flushing</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p><p>Very rare</p></td><td style="vertical-align:top"><p>Hypotension</p><p>Vasculitis</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Dyspnea</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Gastrointestinal disorders</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>Common</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Uncommon</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Cough, rhinitis</p><p>Abdominal pain, nausea, dyspepsia, altered bowel habits (including diarrhea and constipation)</p><p>&nbsp;</p><p>Vomiting, dry mouth</p><p>Pancreatitis, gastritis, gingival hyperplasia</p><p>&nbsp;</p><p>&nbsp;</p><p>Hepatitis, jaundice, hepatic enzyme increased*</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>Alopecia, purpura, skin discoloration, hyperhidrosis, pruritus, rash, exanthema, urticaria</p><p>&nbsp;</p><p>Angioedema, erythema multiforme, exfoliative dermatitis, StevensJohnson syndrome, Quincke edema, photosensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>Ankle swelling, muscle cramps</p><p>Arthralgia, myalgia, back pain</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Micturition disorder, nocturia, increased urinary frequency</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Impotence, gynecomastia</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Common</p><p>Uncommon</p></td><td style="vertical-align:top"><p>Fatigue, asthenia</p><p>Chest pain, pain, malaise</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Weight increased, weight decreased</p></td></tr></tbody></table><p>*mostly consistent with cholestasis Exceptional cases of extrapyramidal syndrome have been reported.</p><p>&nbsp;</p><p>To report any side effect(s): The National Pharmacovigilance and Drug Safety Centre (NPC) o Fax: +966-11-205-7662 o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340. o Toll free phone: 8002490000 o E-mail: npc.drug@sfda.gov.sa o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In humans experience with intentional overdose is limited. Symptoms Available data suggest that gross over dosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported. Treatment Clinically significant hypotension due to amlodipine over dosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine. Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Calcium channel blockers, selective calcium channel blockers with mainly vascular effects. ATC Code: C08CA01. Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. The mechanism of the antihypertensive action of amlodipine is due to a direct relaxant effect on vascular smooth muscle. The precise mechanism by which amlodipine relieves angina has not been fully determined but amlodipine reduces total ischaemic burden by the following two actions. 1) Amlodipine dilates peripheral arterioles and thus, reduces the total peripheral resistance</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption, distribution, plasma protein binding<strong><em>: </em></strong>After oral administration of therapeutic doses, amlodipine is well absorbed with peak blood levels between 6-12 hours post dose. Absolute bioavailability has been estimated to be between 64 and 80%. The volume of distribution is approximately 21 l/kg. <em>In vitro </em>studies have shown that approximately 97.5% of circulating amlodipine is bound to plasma proteins.</p><p>The bioavailability of amlodipine is not affected by food intake.</p><p><em>Biotransformation/elimination</em></p><p>The terminal plasma elimination half life is about 35-50 hours and is consistent with once daily dosing. Amlodipine is extensively metabolised by the liver to inactive metabolites with 10% of the parent compound and 60% of metabolites excreted in the urine.</p><p><em>Use in hepatic impairment</em></p><p>Very limited clinical data are available regarding amlodipine administration in patients with hepatic impairment. Patients with hepatic insufficiency have decreased clearance of amlodipine resulting in a longer half-life and an increase in AUC of approximately 40-60%.</p><p><em>Use in the elderly</em></p><p>The time to reach peak plasma concentrations of amlodipine is similar in elderly and younger subjects. Amlodipine clearance tends to be decreased with resulting increases in AUC and elimination half-life in elderly patients. Increases in AUC and elimination half-life in patients with congestive heart failure were as expected for the patient age group studied.</p><p><em>Use in children</em></p><p>A population PK study has been conducted in 74 hypertensive children aged from 1 to 17 years (with 34 patients aged 6 to 12 years and 28 patients aged 13 to 17 years) receiving amlodipine between 1.25 and 20 mg given either once or twice daily. In children 6 to 12 years and in adolescents 13-17 years of age the typical oral clearance (CL/F) was 22.5 and 27.4 L/hr respectively in males and 16.4 and 21.3 L/hr respectively in females. Large variability in exposure between individuals was observed. Data reported in children below 6 years is limited.</p><p>(afterload) against which the heart works. Since the heart rate remains stable, this unloading of the heart reduces myocardial energy consumption and oxygen requirements. 2) The mechanism of action of amlodipine also probably involves dilatation of the main coronary arteries and coronary arterioles, both in normal and ischaemic regions. This dilatation increases myocardial oxygen delivery in patients with coronary artery spasm (Prinzmetal&#39;s or variant angina). In patients with hypertension, once daily dosing provides clinically significant reductions of blood pressure in both the supine and standing positions throughout the 24 hour interval. Due to the slow onset of action, acute hypotension is not a feature of amlodipine administration. In patients with angina, once daily administration of amlodipine increases total exercise time, time to angina onset, and time to 1 mm ST segment depression, and decreases both angina attack frequency and glyceryl trinitrate capsule consumption. Amlodipine has not been associated with any adverse metabolic effects or changes in plasma lipids and is suitable for use in patients with asthma, diabetes, and gout. Use in patients with coronary artery disease (CAD) The effectiveness of amlodipine in preventing clinical events in patients with coronary artery disease (CAD) has been evaluated in an independent, multi-centre, randomized, double- blind, placebo-controlled study of 1997 patients; Comparison of Amlodipine vs. Enalapril to Limit Occurrences of Thrombosis (CAMELOT). Of these patients, 663 were treated with amlodipine 5-10 mg, 673 patients were treated with enalapril 10-20 mg, and 655 patients were treated with placebo, in addition to standard care of statins, betablockers, diuretics and aspirin, for 2 years. The key efficacy results are presented in Table 1. The results indicate that amlodipine treatment was associated with fewer hospitalizations for angina and revascularization procedures in patients with CAD.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Cardiovascular event rates, No. (%)</p></td><td colspan="3" style="vertical-align:top"><p>Amlopidine vs. Placebo</p></td></tr><tr><td style="vertical-align:top"><p>Outcomes</p></td><td style="vertical-align:top"><p>Amlopidine</p></td><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>Enalapril</p></td><td style="vertical-align:top"><p>Hazard Ratio (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>P Value</p></td></tr><tr><td style="vertical-align:top"><p>Primary Endpoint</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Adverse cardiovascular events</p></td><td style="vertical-align:top"><p>110 (16.6)</p></td><td style="vertical-align:top"><p>151 (23.1)</p></td><td style="vertical-align:top"><p>136 (20.2)</p></td><td colspan="2" style="vertical-align:top"><p>0.69 (0.54-0.88)</p></td><td style="vertical-align:top"><p>.003</p></td></tr><tr><td style="vertical-align:top"><p>Individual Components</p><p>Coronary revascularization</p><p>&nbsp;</p><p>Hospitalization for angina</p><p>&nbsp;</p><p>Nonfatal MI</p><p>&nbsp;</p><p>Stroke or TIA</p><p>&nbsp;</p><p>Cardiovascular death</p><p>&nbsp;</p><p>Hospitalization for CHF</p><p>&nbsp;</p><p>Resuscitated cardiac arrest</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>78 (11.8)</p><p>&nbsp;</p><p>&nbsp;</p><p>51 (7.7)</p><p>&nbsp;</p><p>14 (2.1)</p><p>&nbsp;</p><p>6 (0.9)</p><p>&nbsp;</p><p>5 (0.8)</p><p>&nbsp;</p><p>&nbsp;</p><p>3 (0.5)</p><p>&nbsp;</p><p>&nbsp;</p><p>0</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>103 (15.7)</p><p>&nbsp;</p><p>&nbsp;</p><p>84 (12.8)</p><p>&nbsp;</p><p>19 (2.9)</p><p>&nbsp;</p><p>12 (1.8)</p><p>&nbsp;</p><p>2 (0.3)</p><p>&nbsp;</p><p>&nbsp;</p><p>5 (0.8)</p><p>&nbsp;</p><p>&nbsp;</p><p>4 (0.6)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>95 (14.1)</p><p>&nbsp;</p><p>&nbsp;</p><p>86 (12.8)</p><p>&nbsp;</p><p>11 (1.6)</p><p>&nbsp;</p><p>8 (1.2)</p><p>&nbsp;</p><p>5 (0.7)</p><p>&nbsp;</p><p>&nbsp;</p><p>4 (0.6)</p><p>&nbsp;</p><p>&nbsp;</p><p>1 (0.1)</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>0.73 (0.54-0.98)</p><p>&nbsp;</p><p>0.58 (0.41-0.82</p><p>&nbsp;</p><p>&nbsp;</p><p>0.73 (0.37-1.46)</p><p>&nbsp;</p><p>0.50 (0.19-1.32)</p><p>&nbsp;</p><p>2.46 (0.48-12.7)</p><p>&nbsp;</p><p>&nbsp;</p><p>0.59 (0.14-2.47)</p><p>&nbsp;</p><p>&nbsp;</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>.03</p><p>&nbsp;</p><p>.002</p><p>&nbsp;</p><p>&nbsp;</p><p>.37</p><p>&nbsp;</p><p>.15</p><p>&nbsp;</p><p>.27</p><p>&nbsp;</p><p>&nbsp;</p><p>.46</p><p>&nbsp;</p><p>&nbsp;</p><p>.04</p></td></tr><tr><td style="vertical-align:top"><p>New-onset peripheral vascular disease</p></td><td style="vertical-align:top"><p>5 (0.8)</p></td><td style="vertical-align:top"><p>2 (0.3)</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>8 (1.2)</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p><p>2.6 (0.50-13.4)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>.24</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>Abbreviations: CHF, congestive heart failure; CI, confidence interval; MI, myocardial infarction; TIA, transient ischemic attack. Use in Patients with Heart Failure Haemodynamic studies and exercise based controlled clinical trials in NYHA Class II-IV heart failure patients have shown that Amlodipine did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction and clinical symptomatology. A placebo controlled study (PRAISE) designed to evaluate patients in NYHA Class III-IV heart failure receiving digoxin, diuretics and ACE inhibitors has shown that Amlodipine did not lead to an increase in risk of mortality or combined mortality and morbidity with heart failure. In a follow-up, long term, placebo controlled study (PRAISE-2) of Amlodipine in patients with NYHA III and IV heart failure without clinical symptoms or objective findings suggestive or underlying ischaemic disease, on stable doses of ACE inhibitors, digitalis, and diuretics, Amlodipine had no effect on total cardiovascular mortality. In this same population Amlodipine was associated with increased reports of pulmonary oedema</p><p>&nbsp;</p><p><strong>Treatment to prevent heart attack trial (ALLHAT)</strong></p><p>A randomized double-blind morbidity-mortality study called the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was performed to compare newer drug therapies: amlodipine 2.5-10 mg/d (calcium channel blocker) or lisinopril 10-40 mg/d (ACE-inhibitor) as first-line therapies to that of the thiazide-diuretic, chlorthalidone 12.5-25 mg/d in mild to moderate hypertension. A total of 33,357 hypertensive patients aged 55 or older were randomized and followed for a mean of 4.9 years. The patients had at least one additional CHD risk factor, including: previous myocardial infarction or stroke (&gt; 6 months prior to enrollment) or documentation of other atherosclerotic CVD (overall 51.5%), type 2 diabetes (36.1%), HDL-C &lt; 35 mg/dL (11.6%), left ventricular hypertrophy diagnosed by electrocardiogram or echocardiography (20.9%), current cigarette smoking (21.9%). The primary endpoint was a composite of fatal CHD or non-fatal myocardial infarction. There was no significant difference in the primary endpoint between amlodipine-based therapy and chlorthalidone-based therapy: RR 0.98 95% CI(0.90-1.07) p=0.65. Among secondary endpoints, the incidence of heart failure (component of a composite combined&nbsp;cardiovascular endpoint) was significantly higher in the amlodipine group as compared to the chlorthalidone group (10.2% % vs 7.7%, RR 1.38, 95% CI [1.25- 1.52] p&lt;0.001). However, there was no significant difference in all-cause mortality between amlodipinebased therapy and chlorthalidone-based therapy. RR 0.96 95% CI [0.89-1.02] p=0.20. Use in children (aged 6 years and older) In a study involving 268 children aged 6-17 years with predominantly secondary hypertension, comparison of a 2.5 mg dose, and 5.0 mg dose of amlodipine with placebo, showed that both doses reduced Systolic Blood Pressure significantly more than placebo. The difference between the two doses was not statistically significant. The long-term effects of amlodipine on growth, puberty and general development have not been studied. The long-term efficacy of amlodipine on therapy in childhood to reduce cardiovascular morbidity and mortality in adulthood have also not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reproductive toxicology Reproductive studies in rats and mice have shown delayed date of delivery, prolonged duration of labor and decreased pup survival at dosages approximately 50 times greater than the maximum recommended dosage for humans based on mg/kg. Impairment of fertility There was no effect on the fertility of rats treated with amlodipine (males for 64 days and females 14 days prior to mating) at doses up to 10 mg/kg/day (8 times* the maximum recommended human dose of 10 mg on a mg/m2 basis). In another rat study in which male rats were treated with amlodipine besilate for 30 days at a dose comparable with the human dose based on mg/kg, decreased plasma follicle-stimulating hormone and testosterone were found as well as decreases in sperm density and in the number of mature spermatids and Sertoli cells. Carcinogenesis, mutagenesis Rats and mice treated with amlodipine in the diet for two years, at concentrations calculated to provide daily dosage levels of 0.5, 1.25, and 2.5 mg/kg/day showed no evidence of carcinogenicity. The highest dose (for mice, similar to, and for rats twice* the maximum recommended clinical dose of 10 mg on a mg/m2 basis) was close to the maximum tolerated dose for mice but not for rats. Mutagenicity studies revealed no drug related effects at either the gene or chromosome levels.</p><p>*Based on patient weight of 50 kg</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Avicel PH 102 Maize Starch Magnesium Stearate Gelatin Caps</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                48 Months/4Years (5mg), 36Months/3Years (10mg)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>30/pack Transparent Thermoformed PVC/PVDC and hard tempered aluminium foil lid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No Special Disposal<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2016.

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>